Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 3-Greece bans export of 25 drugs after pharmacists' supply warnings

Tue, 14th Jul 2015 17:14

(Adds AstraZeneca comment)

By Lefteris Karagiannopoulos

ATHENS, July 14 (Reuters) - Greece has decided to ban theexport of 25 types of drugs, the Health Ministry said onTuesday, following warnings of possible shortages that riskedleading to a humanitarian crisis.

A ministry spokeswoman quoted the Greek drugs regulator assaying there had been a significant increase in some importedmedicines being shipped back out of the country.

"Abuses by some players in the pharmaceuticals market havebeen discovered," she told Reuters.

The regulator made the warning on re-exports during ameeting at the Health Ministry on Friday, when pharmacistscomplained they faced difficulties in securing some supplies.

The spokeswoman said the ministry would closely checkexports and re-exports over the past 15 days and file complaintsat home and abroad where there is evidence of abuse. Shedeclined to say which drugs would be included in the ban.

However, the head of the drugs wholesalers' association saidthe group had not yet been informed of the ban.

The ban was the latest move in a row over the availabilityof drugs in Greece, with pharmacists, drugmakers, wholesalersand public authorities trading blame while rights group warn ofworsening public health conditions during the economic crisis.

Difficulties over drug supplies in Greece are compounded bycapital controls which prevent companies from sending moneyabroad, imposed last month to prevent the banking system fromcollapse.

Re-exporting drugs across European borders, which allowstraders to buy products in low-cost markets and sell them whereprices are higher, is permitted under European Union free traderules.

Drugmakers have nevertheless urged a curb on re-exports toprevent shortages in Greece but wholesalers trading medicineshave denied the need for such emergency action.

The European Federation of Pharmaceutical Industries andAssociations (EFPIA), which represents 40 drug companies, calledon Tuesday for "exceptional measures" in "exceptionalcircumstances".

"A proportionate, legislative ban on exporting medicinesintended for Greek patients from Greece would be an appropriateand justifiable response to possible shortages and help to averta potential humanitarian crisis," it said in a statement.

But the head of the Hellenic Association of MedicineWholesalers, Eirini Markaki, pointed the finger at internationaldrugmakers and pharmacists. "Most of the internationalpharmaceutical companies have issued quotas on the amount ofsupplies Greek warehouses can order," Markaki told Reuters.

"We have filed official complaints to the regulator so thatmeasures are taken for this to stop," she said, adding that thecomplaints targeted AstraZeneca, Novartis andJanssen, a unit of Johnson & Johnson. Novartis deniedthat it had limited its supplies to Greece, while Janssen wasnot immediately available for comment.

ASTRAZENECA DENIAL

A spokesperson for AstraZeneca said the firm had met theregulator last week "to dispute the allegations made by theHellenic Association of Pharmaceutical Warehouses".

At that meeting, AstraZeneca said, it had "provided evidenceto demonstrate that we continue to deliver in excess of thequantities of medicines currently required in the Greek market".

Markaki denied any overall increase in re-exports bywholesalers. She said an isolated case of one warehouseexporting 700,000 units of drugs in two days at the end of Junewas under investigation, but all the warehouses combined hadexported only 179,000 items so far in July.

Demand for drugs had increased because customers were tryingto build up their supplies, fearing future shortages, she added.

The pharmaceuticals industry is owed more than 1.1 billioneuros by Greek hospitals and the state-run health insurer inunpaid bills since December but it has promised to keep supplylines open on humanitarian grounds.

Separately, Greek pharmacists will go on strike on Wednesdayto protest about plans in a deal struck between Athens and itsinternational lenders on Monday to make changes to their trade.These include allowing people without a pharmacist's degree toopen a pharmacy. (Additional reporting by Kate Kelland in London; Writing byIngrid Melander; Editing by David Stamp)

More News
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.